Eprosartan

CHEMBL813 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

424.5 g/mol

LogP

4.5

Phase

4

This medication blocks a receptor for angiotensin II, a hormone that constricts blood vessels, allowing vessels to relax and blood pressure to fall. It is used to treat high blood pressure and protect kidney function.

Moleküler Ağırlık

424,5000 g/mol

LogP

4,50

TPSA

121,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Chronic Kidney Disease Stroke Obesity Type 2 Diabetes Hypertension Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1

InChI

InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

Molecular Formula

C23H24N2O4S

HBD / HBA

2 / 6

Döndürülebilir Bağlar

10

Ağır Atomlar

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication blocks a receptor for angiotensin II, a hormone that constricts blood vessels, allowing vessels to relax and blood pressure to fall. It is used to treat high blood pressure and protect kidney function.

Yes, Eprosartan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL813. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5281037. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Eprosartan PillFYI'da

Yapı

Hızlı Veriler

Formül: C23H24N2O4S
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.